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The Notch receptor is a key component of a core
metazoan signaling pathway activated by Delta/
Serrate/Lag-2 ligands expressed on an adjacent
cell. This results in a short-range signal with profound
effects on cell-fate determination, cell proliferation,
and cell death. Key to understanding receptor func-
tion is structural knowledge of the large extracel-
lular portion of Notch which contains multiple
repeats of epidermal growth factor (EGF)-like do-
mains. Here we investigate the EGF4-13 region of
human Notch1 (hN1) using a multidisciplinary
approach. Ca2+-binding measurements, X-ray crys-
tallography, {1H}-15N heteronuclear nuclear Over-
hauser effects, and residual dipolar couplings sup-
port a non-linear organization for the EGF4-13
region with a rigid, bent conformation for EGF4-7
and a single flexible linkage between EGF9 and
EGF10. These data allow us to construct an informed
model for EGF10-13 which, in conjunction with
comparative binding studies, demonstrates that
EGF10 has an important role in determining Notch
receptor sensitivity to Dll-4.
INTRODUCTION
TheNotchpathway plays a key role in cell-fate determination, cell
proliferation, and apoptosis during development with a crucial
impact on most tissues and organs (Artavanis-Tsakonas et al.,
1999; Bray, 2006). In adults, Notch has key roles in tissue homeo-
stasis by regulating stem cell maintenance and function, immune
system activation, and angiogenesis. The importance of the
Notch pathway for human biology is underscored by the number
of diseases resulting from its inappropriate activation or inhibi-
tion, including a number of inherited disorders and cancers (Louvi
and Artavanis-Tsakonas, 2012; Ntziachristos et al., 2014).
Notch signaling requires cell-surface expression of a hetero-
dimeric transmembrane Notch receptor, which has a large extra-
cellular portion rich in epidermal growth factor (EGF)-like domains
(36 in human Notch1 and Drosophila Notch) (Figure 1A). Ligandbinding to Notch EGF11-12 by one of the two DSL ligand families
(Jagged/SerrateorDelta) initiates regulated intramembraneprote-
olysis,where the receptor is cleavedwithin the negative regulatory
region (NRR) by an ADAM metalloprotease and subsequently
by the g-secretase enzyme complex (Blaumueller et al., 1997;
Gordon et al., 2007; Logeat et al., 1998; Sanchez-Irizarry et al.,
2004). The final intramembrane cleavage releases the intracellular
domain of Notch, which comprises RAM, ANK, and PEST se-
quences (Mumm and Kopan, 2000; Schroeter et al., 1998). This
translocates to the nucleus, binds to a transcription factor of the
CBF1,SuppressorofHairless,Lag-1 (CSL) family, and, in thepres-
enceof co-activators suchasMastermind (MAM), relieves repres-
sion of genes of the HES and Hey families (Jarriault et al., 1995).
Interactions with the Notch receptor can activate or inhibit
Notch signaling, dependent upon whether cell-surface ligands
are presented to Notch on adjacent cells (in trans), or on the
same cell (in cis) (deCelis and Bray, 1997; Franklin et al., 1999).
Notch ligandactivity isalsosensitive to themodificationofO-fuco-
sylated Notch by Fringe (Moloney et al., 2000a, 2000b; Rana and
Haltiwanger, 2011; Shao et al., 2003). This can potentiate or pre-
vent signaling bydifferent ligands and this post-translational regu-
lation is important in controlling embryonic patterning and bound-
ary formation between adjacent developmental compartments
(Johnston et al., 1997). In addition, O-glucosylation of Notch has
been shown to be essential for activity (Acar et al., 2008).
Structural studies have informed on the ligand-binding
EGF11-13 (Cordle et al., 2008a; Hambleton et al., 2004) and
the NRR (Gordon et al., 2007) regions of the extracellular
domain of Notch. Furthermore, the structure of the transcrip-
tional complex formed by CSL, Notch intracellular domain
(NICD), and MAM in combination with DNA has been solved
(Nam et al., 2006; Wilson and Kovall, 2006); however, most
of the extracellular region remains unsolved. New structural
information for the EGF-rich regions of the receptor and, in
particular, those flanking the ligand-binding region are essen-
tial to gain mechanistic insight into the processes of receptor
activation and inhibition that occur when ligand is expressed
in trans or cis, respectively, and to explain the effects of
various mutations and post-translational modifications such
as O-glycosylation. The three EGF domains of the ligand-bind-
ing site all adopt a canonical EGF fold and each contains a
Ca2+-binding site at its N terminus, which together with a
conserved hydrophobic packing interaction results in a near-
linear and rigid conformation (Cordle et al., 2008a; HambletonStructure 24, 555–566, April 5, 2016 ª2016 The Authors 555
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Figure 1. Modular Organization of the
Extracellular Domain of Human Notch1 and
Overview of Ca2+ Dissociation Constants
(A) The negative regulatory region (NRR) and
transmembrane domain (TM) of Notch1 are indi-
cated. Individual domains belonging to the Notch
intracellular domain (NICD) are not indicated
separately. Ca2+-binding and non-Ca2+-binding
EGF domains are indicated in green and wheat,
respectively. The thick horizontal black line high-
lights the EGF4-13 region that is the subject of this
study. The shorter lines indicate the principal
constructs used here (EGF4-7, EGF7-9, EGF8-11,
and EGF11-13).
(B) The measured Ca2+ dissociation constants at
pH 7.5 and I = 0.15 for all the constructs studied
are shown. Kd values in the 1–20 mM range were
determined by chromophoric chelation; at least
three repeats were carried out and the experi-
mental errors on the Kd values are shown. Kd
values in the 20 mM to mM range were determined
by NMR; repeat experiments were not carried out.
Ca2+ is indicated by a red sphere at the N terminus
of each Ca2+-binding EGF domain. EGF11-13
contains a recognition sequence for the site-spe-
cific biotinylation enzyme BirA at its C terminus.
The N-terminal His6 tag has not been cleaved from
EGF7-9 and EGF9-11.
See also Figures S1 and S4.et al., 2004). Many of the other EGF domains are predicted
to bind Ca2+ and, by homology to known structures, are
expected to adopt extended inflexible structures similar to
EGF11-13 (Downing et al., 1996; Handford et al., 1991; Rees
et al., 1988). However, the multiple tandem repeats of
Ca2+-binding EGF-like domains are interspersed with non-
Ca2+-binding domains EGF6, EGF10, and EGF22, which may
introduce sites of flexibility or adopt non-linear pairwise
domain interactions (Figure 1A). An electron microscopy study
suggested the existence of a Notch dimer with distinct confor-
mational states (Kelly et al., 2010) but these data were ob-
tained using affinity grid immobilization without conventional
protein purification, and the Ca2+ concentration was ill defined.
A ‘‘jack-knife’’ model for the receptor has been proposed to
explain the genetic data (Xu et al., 2005), but there is as yet
no direct experimental evidence for this, and a conformation
that extends the receptor ectodomain away from the cell sur-
face toward the ligand is also possible. Recently, the structure
of EGF11-13 in complex with the N-terminal fragment of Dll-4
(NE1) has been reported, which shows the two molecules in an
antiparallel orientation within the crystal (Luca et al., 2015).
Furthermore, two distinct sites within EGF11-12 were shown
to bind to Dll-4, with specific residues within EGF12 binding
to the N-terminal C2 domain of the ligand and EGF11 residues
making contacts with the DSL domain.
In this study, we have used nuclear magnetic resonance
(NMR) spectroscopy and X-ray crystallography to investigate556 Structure 24, 555–566, April 5, 2016 ª2016 The Authorsthe structure and flexibility of the EGF4-
13 region of the Notch ectodomain by
analyzing a series of limited fragments
with the non-Ca2+-binding EGF6 andEGF10 domains placed in a native context (Figure 1A). We report
a crystal structure of EGF4-7, where the domain interface formed
between the non-Ca2+-binding domain, EGF6, and its preceding
domain introduces a bent conformation to the region. Residual
dipolar coupling measurements are used to define interdomain
orientations for other domain pairs in EGF4-13 and identify a
single site of flexibility at the EGF9-10 linker. These data,
together with Ca2+-binding and {1H} -15N heteronuclear nuclear
Overhauser effect (NOE) measurements, allow modeling of
EGF4-13, which suggests a non-linear, but not jack-knifed,
organization. Superposition of EGF10-13 on EGF11-13 of the
recently solved Notch/Dll-4 complex indicates that further inter-
action sites with ligand outside the core recognition site are
possible, notably at EGF10/EGF1. Comparative binding ana-
lyses, by flow cytometry, indicate that the presence of EGF10
modulates the ability of the core recognition site to interact
with Dll-4, but not Jagged1 (J1), revealing greater complexity
to the molecular basis of ligand specificity than previously
thought.
RESULTS
Ca2+-Binding Measurements Reveal Rigid Interfaces for
Ca2+-Binding EGF Domains in the EGF4-13 Region of
Human Notch1
Ca2+ affinities for Ca2+-binding (cb) EGF domains of the EGF4-
13 region of human Notch1 were measured to gain insight into
Table 1. Crystallization and Structure Determination for hN1
EGF4-7
Space Group P21 C2
Cell
a, b, c (A˚) 40.94, 86.83,
53.45
142.26, 21.15,
83.56
a, b, g () 90, 107, 90 90, 116.27, 90
Wavelength (A˚) 1.74626 1.74626
Resolution (A˚) 43.42–2.46
(2.69–2.46)
64.73–2.92
(3.26–2.92)
Rmerge (%) 3.0 (38.8) 3.1 (36.8)
I/sI 23.6 (2.3) 17.4 (2.1)
Completeness (%) 89.9 (93.8) 95.0 (98.0)
Redundancy 3.3 3
Number of reflections 39,951 15,128
Rwork/Rfree (%) 25.9/26.3 21.4/23.7
Number of atoms
Protein 4,154 2,099
Ligand/ion 29 8
Water 18 6
B factors
Protein 69.2 34.4
Ligand/ion 66.0 40.5
Water 56.0 17.3
RMS deviation
Bond length (A˚) 0.035 0.01
Bond angles () 1.21 1.23
Residues in allowed
regions of Ramachandran
plot (%)
100 100
Residues in favored
regions of Ramachandran
plot (%)
97.3 95.4
Table 2. Interdomain Tilt and Twist Angles Observed in X-Ray
Structures and Obtained from RDC Data
X-Ray Structuresa
Construct
Domain
Pair
Range of Tilt
Angles
Range of Twist
Angles
EGF4-7 EGF4-5 33–42 179–187
EGF4-7 EGF5-6 82–92 112–123
EGF4-7 EGF6-7 25–36 146–154
EGF11-13 EGF11-12 14–18 119–141
EGF11-13 EGF12-13 10–24 132–141
RDC datab
Construct Domain Pair Tilt Angle Twist Angle
EGF4-7 EGF4-5 48 ± 3 190 ± 6
EGF4-7 EGF5-6 70 ± 2 112 ± 7
EGF4-7 EGF6-7 30 ± 3 153 ± 4
EGF7-9 EGF7-8 45 ± 2 192 ± 17
EGF8-11 EGF8-9 14 ± 2 142 ± 9
EGF8-11c EGF9-10 not defined not defined
EGF8-11 EGF10-11 33 ± 10 172 ± 3
EGF11-13 EGF11-12 19 ± 2 133 ± 8
EGF11-13 EGF12-13 16 ± 1 149 ± 9
aThe ranges in the tilt and twist angles (Downing et al., 1996) for EGF4-7
were obtained from the two proteinmolecules in the P21 unit cell and from
the single molecule in the C2 unit cell. The ranges for EGF11-13 were
obtained from several X-ray structures determined for EGF11-13 (PDB:
2VJ3, 4CUE, 4CUF, 4D0F, 4CUD, 4D0E).
bErrors in the angles are determined using an experimental error of 2 Hz
for the RDCs as described in Supplemental Experimental Procedures
(see also Figure S2, Tables S1 and S2).
cSee also Figure S3.the rigidity of interdomain interfaces in this region. In EGF do-
mains, a consensus sequence of D/N-x-D/N-E/Q-xm-D/N*-xn-
Y/F (where * indicates possible b-hydroxylation, and m/n are
variable) is predictive for Ca2+ binding (Handford et al., 1991;
Mayhew et al., 1992; Rand et al., 2000; Rees et al., 1988). Chro-
mophoric chelation was used to measure Kd values for high-af-
finity sites (up to20 mM (Jensen et al., 2005; Linse et al., 1991)),
while NMR titrations were used to measure Kd values for low-
and medium-affinity sites and to assign the high-affinity sites
to specific EGF domains (Figure 1B) (Suk et al., 2004). Ca2+-
binding EGF domains 5, 8, 11, 12, and 13 show the consensus
Ca2+ binding sequence and the aromatic packing residue in the
preceding domains. EGF domains 7 and 9 have an aspartic acid
instead of the expected E/Q at the third consensus site
(Figure S1).
Ca2+ affinities were measured in a number of constructs and
the results are summarized in Figure 1B. N-terminal EGF
domains have low affinity for Ca2+, and this is observed to in-
crease when they are placed in a native context with a preced-
ing EGF domain. For example, the affinity for Ca2+ of EGF5 is
increased by 100-fold (from a Kd of 19 mM to a Kd of 170 mM)
when it is preceded by EGF4. In the domains for which Kdvalues have been measured, only the presence of a preceding
domain has an influence on the Kd value. For example, EGF9
has the same Kd, within experimental error, in the EGF7-9
and EGF8-11 constructs. The Kd values for EGF domains 7,
8, 9, 11, 12, and 13 are in the range of 1–60 mM, and under
the conditions of extracellular Ca2+ concentration (1.4 mM)
(Breitwieser, 2008) these sites will be saturated to >95%.
EGF5 has a weaker affinity for Ca2+ (Kd 170 mM); this site
will still be occupied in 90% of molecules. The high Ca2+ af-
finity observed for all the cbEGF domains (including EGF7 and
EGF9, which have aspartic acid instead of the expected E/Q at
the third consensus site), and the observation that the affinity
is enhanced by at least a factor of 50 when a preceding
domain is present, suggests that the cbEGF domains studied
here form a packing interaction with the preceding domain
leading to a rigid interdomain interface.
Crystal Structure of Human Notch1 EGF4-7 Reveals a
Bent Conformation
Structures of two crystal forms (P21 and C2) were determined for
hN1 EGF4-7 using X-ray crystallography (Table 1). Each domain
within the construct displayed a canonical EGF fold, with a single
Ca2+ bound, as expected, to EGF5 and EGF7 (Handford et al.,
1991; Mayhew et al., 1992; Rees et al., 1988). An unusual
tilt angle of 80–90 was observed at the domain interface of
EGF5 and EGF6 for both crystal forms resulting in a bentStructure 24, 555–566, April 5, 2016 ª2016 The Authors 557
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Figure 2. Structure of EGF4-7 Reveals the
Bent Conformation of the EGF5-6 Junction
(A) X-Ray structures of EGF4-7 (total of three in-
dependent chains in two crystal forms) reveal a
consistent bent structure with the EGF5-6 junction
adopting an 90 tilt angle. The main panel shows
a representative structure (chain A from the P21
crystal form) in a cartoon representation colored
from blue at the N terminus to red at the C terminus.
Ca2+ ions are shown as red spheres and the resi-
dues stabilizing the EGF5-6 junction highlighted in
stick and van der Waals surface representations
colored to highlight the side chains that pack
together. The EGF5-6 junction is also shown in the
zoom box with the same representation.
(B) Comparison of experimental RDCs for EGF4-7
to RDC values calculated using the X-ray structure
(P21 A) (red circles) or a structure in which the
EGF5-6 interdomain tilt angle was reduced from
90 to 70 (blue circles); the Q value decreases from
0.38 to 0.27 when the tilt angle is decreased.
(C) Overlay of the three X-ray structures (red) and
RDC-modeled structures (blue) for EGF4-7; the two
structures in blue represent the range of tilt angles
obtained from the RDC data using Monte Carlo
simulations with an experimental error of 2 Hz (see
also Table S2). The Ca2+ ions bound to EGF5 and
EGF7 are shown as spheres.
See also Figure S2 and Tables S1 and S2.conformation for this stretch of EGF domains (Table 2 and Fig-
ure 2A). The EGF5-6 domain interface is stabilized in this orien-
tation by packing of the side chain of A208 (with some contribu-
tion of T209) in EGF5 with V239 from EGF6. A second packing
interaction is also evident between Y219 and P221 at the N ter-
minus of EGF6 (Figure 2A). These interactions are very different
from the interdomain packing typically observed in cbEGF-
cbEGF pairs, and EGF-cbEGF pairs, which involves a conserved
aromatic residue located between the fifth and sixth cysteine
in the N-terminal domain packing against residues on the major
b hairpin of the C-terminal domain, resulting in a rod-shaped
conformation (Cordle et al., 2008a; Downing et al., 1996; Ham-
bleton et al., 2004; Smallridge et al., 2003). H210, which is
located at the position of the conserved packing aromatic resi-
due in EGF5, is instead involved in an intradomain interaction
with H191 that helps to stabilize the loop containing A208. The
EGF4-5 and EGF6-7 pairs adopt a more elongated conformation
than observed for EGF5-EGF6, but these pairs are not as elon-
gated as the previously determined structure for EGF11-13
(Table 2).
Heteronuclear NOE Measurements Show that
Interdomain Linkers Are Not Flexible on a Fast
Timescale
The {1H} -15N heteronuclear NOE provides a method for identi-
fying regions of the polypeptide backbone that undergo fast558 Structure 24, 555–566, April 5, 2016 ª2016 The Authorstimescale dynamics (picoseconds/nano-
seconds) (Palmer, 2004). Data for the
EGF4-7, EGF7-9, EGF8-11, and EGF11-
13 constructs are shown in Figure 3.
Reduced values of the heteronuclearNOE, characteristic of mobile residues, are observed for up to
approximately four residues at the N terminus of each construct.
EGF8 andEGF11 show reducedNOE values for some residues in
the loop between the first and second cysteines. In both cases,
this flexibility is observed when EGF8 or EGF11 is the N-terminal
domain but also when it is preceded by EGF7 or EGF10. EGF8
and EGF11 have six residues in this loop in contrast to only four
residues in Ca2+-binding EGF7, EGF9, EGF12, and EGF13where
flexibility is not observed. Other regions of the construct do not
show evidence for fast timescale dynamics. In particular, the res-
idues between the sixth cysteine of one domain and first cysteine
of the following domain, which represent the interdomain linker,
do not show evidence of low heteronuclear NOE ratios suggest-
ing that interdomain flexibility, at least on a fast timescale (pico-
second to nanosecond), is absent.
Interdomain Orientations Determined using Residual
Dipolar Couplings
Residual dipolar couplings (RDCs) are a useful NMR parameter
for assessing the relative orientations of protein domains in solu-
tion and for identifying interdomain dynamics on a wider range of
timescales than the heteronuclear NOE (Braddock et al., 2001;
Chen and Tjandra, 2012; Fischer et al., 1999; Prestegard et al.,
2004; Tolman and Ruan, 2006). 1HN-15N RDCs were measured
for EGF4-7, EGF7-9, EGF8-11, and EGF11-13 using C12E6/n-
hexanol as the alignment medium (Figure S2, and Tables S1
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Figure 3. {1H} -15N Heteronuclear NOE Data
for hN1 Constructs
(A–D)Data areshown for (A)EGF4-7, (B)EGF7-9, (C)
EGF8-11 and (D) EGF11-13. Reduced NOE ratios,
characteristic of significant mobility on a nano-
second to picosecond timescale, are observed at
the N terminus of each construct and for the loop
between the first and second Cys in EGF8 and
EGF11 (indicated by an asterisk). The regions
highlighted by the dashed vertical lines and shading
represent the linker between pairs of EGF domains
(six residues between the sixth Cys of one domain
and the first cysteine of the next for all linkers except
EGF9-10 which has five residues). It is clear that
reducedNOE ratios arenotobserved in anyof these
linkers, indicating that they are not flexible on a fast
timescale. EGF4 shows reduced NOE values for
residues 158–161. These residues are located in the
b turn between the third and fourth Cys; in the X-ray
structures of EGF4-7 these residues show high
B factors or missing electron density suggesting
dynamic behavior. Uncertainties in the NOE ratios
were estimated from 500 Monte Carlo simulations
using baseline noise as ameasure of the error in the
peak heights.and S2) (Ruckert and Otting, 2000). The interdomain tilt and twist
angles determined using these RDC data are summarized in
Table 2.Structure 24, 555Well-Defined Interfaces Observed
for all Ca2+-Binding EGF Domains
The RDC data demonstrate that all Ca2+-
binding EGF domains found in a native
context have a well-defined and rigid
interdomain interface; this is consistent
with the conclusions from the Ca2+ affin-
ity measurements. For the EGF4-5,
EGF6-7, EGF11-12, and EGF12-13 pairs,
the interdomain orientations in solution,
as defined by the tilt and twist angles
(Table 2), agree with the orientation
observed in the X-ray structures of
EGF4-7 and EGF11-13.
Crystal structures are not available for
EGF7-9 and EGF8-11. The relative orien-
tations of EGF8 and EGF9 with respect
to EGF4-7 were determined from the
RDCs measured for EGF7-9. The rela-
tive orientation of EGF10 with respect
to EGF11-13 was determined from
the RDCs measured for EGF8-11. The
EGF7-8, EGF8-9, and EGF10-11 inter-
faces show the expected close prox-
imity of the packing aromatic, found
four residues after the fifth cysteine in
the N-terminal domain, to the residues
in the major b turn of the C-terminal
domain (Figure S1); this packing interac-
tion is expected in cbEGF domains with
high affinity for Ca2+ as observed forEGF8, EGF9, and EGF11 (Figure 1B). The EGF7-8 pair has a
tilt angle of 45, showing a less-extended conformation than
observed for EGF11-13. This domain pair has a non-standard–566, April 5, 2016 ª2016 The Authors 559
Figure 4. Models for the EGF4-13 Region of Human Notch1
Themodels for the EGF4-9 (left) and EGF10-13 (right) regions of humanNotch1 are based on the X-ray structures of EGF4-7 andEGF11-13 and on the interdomain
orientations determined using RDC data for EGF7-8, EGF8-9, and EGF10-11. The NMR data indicate that there is no fixed orientation of EGF9 relative to EGF10.
Therefore, numerous relative orientations of EGF4-9 and EGF10-13 are possible. The Ca2+-binding EGF domains are shown in greenwhile the other EGF domains
are shown in wheat. The Ca2+ ions bound in EGF5, EGF7, EGF8, EGF9, EGF11, EGF12, and EGF13 are shown as red spheres.packing interaction involving W287 in EGF7 and H316 in the
b hairpin of EGF8, rather than the more common hydropho-
bic residue; this may influence the interdomain orientation.
EGF10 adopts a less-extended conformation with respect to
EGF11 than the remainder of the EGF11-13 construct with a
tilt angle of 33 ± 10.
EGF4-7 Is Bent in Solution
The X-ray structure of the EGF4-7 construct shows an unusual
bent structure with a tilt angle of 80–90 between EGF5 and
EGF6 (Figure 2A). The RDC data for EGF4-7 suggest that the
molecule tumbles in solution as a rigid object. In solution, the
EGF5-6 interface is also observed to be bent but is somewhat
more open (70 ± 2) than the crystal structures (Figures 2B
and 2C).
The EGF9-10 Interface Is Flexible
Attempts to fit the RDCdata for the four domains of EGF8-11 to a
single alignment tensor result in a significantly higherQvalue than
the individual fits of EGF8-9 and EGF10-11 (Figure S3). In addi-
tion, the Da values, which define the alignment tensor, obtained
from the fits of the RDCs for EGF8-9 and EGF10-11 are signifi-
cantly different in both their magnitude and sign (Da = 14.9 ±
0.5 for EGF8-9 and Da = 8.5 ± 0.3 for EGF10-11) (Table S2).
This suggests that the two pairs of domains align independently
in solution in the EGF8-11 construct; such a result has previously
been interpreted as indicating medium-to-large-scale interdo-
main motion (Braddock et al., 2001). Thus the EGF9-10 interface
appears tobeflexible,which is in linewith thepredictionof EGF10
as a non-Ca2+-binding domain (Hambleton et al., 2004), the
absence of an aromatic consensus residue at position four after
the fifth cysteine in EGF9, and the prediction by TALOS+ (Shen
et al., 2009), on the basis of 1H, 13C and 15N chemical shifts, of
lower order parameters for the residues at the beginning of
EGF10. The absence of reduced heteronuclear NOE values for
the EGF9-10 interface suggests that mobility of this interface is
on a slower microsecond to millisecond timescale. Therefore,560 Structure 24, 555–566, April 5, 2016 ª2016 The Authorswithin the EGF4-13 region of human Notch1, the EGF9-10 inter-
face is the only site of significant interdomain flexibility.
Model of EGF4-13 Region of Human Notch1
The interdomain tilt and twist angles obtained from X-ray struc-
tures and RDC refinement allow a model for the EGF4-13 region
to be constructed (Figure 4). As a result of the flexibility between
EGF9 and EGF10, the model consists of two rigid segments,
EGF4-9 and EGF10-13. Largely as a result of the bent inter-
face between EGF5 and EGF6, EGF4-9 has an L shape with
more extended structure in the EGF7-9 region. The model for
EGF10-13 is more extended but there is a noticeable bend
between EGF10 and EGF11 in contrast to the very linear
EGF11-13 region.
A number of possible orientations will exist for EGF4-9 with
respect to EGF10-13 as a result of the flexible EGF9-10 linker.
A tight U-shaped structure has been reported for an EGF domain
pair from the Merozoite surface protein 1 (Morgan et al., 1999).
This structure contains a number of features not seen for Notch
EGF domains including a seven-residue linker between domains
and significantly longer loops between the fifth and sixth cys-
teines, which contain several hydrophobic residues involved
in the stabilizing interdomain interface. The relatively short linker
of five residues between the sixth cysteine of EGF9 and the first
cysteine of EGF10 means that highly folded, U-shaped confor-
mations are unlikely due to steric clashes.
Implications of the EGF10-EGF13 Model for Ligand
Interactions
The recent X-ray structure of Notch EGF11-13 in an antiparallel
complex with Dll-4 shows interactions between EGF12 of Notch
and the C2 domain of Dll-4 and between EGF11 of Notch and the
DSL domain of Dll-4 (Luca et al., 2015). Our model for human
Notch1 EGF10-13 can be used to provide further insights into
Notch-ligand interactions. EGF10-13 has been superimposed
Figure 5. Model of Potential Interaction between EGF10 of Notch
and EGF1 of Dll-4
(Top) The model of EGF10-13 has been superimposed on EGF11-13 in the
Notch-Dll-4 complex (Luca et al., 2015). Notch domains EGF11-13 and the
Dll-4 C2 and DSL domains are shown as a cartoon representation. EGF10 of
Notch (wheat) and EGF1 of Dll-4 (light brown) are shown in a surface repre-
sentation; this highlights the potential interaction between these two domains.
The Ca2+-binding EGF domains are shown in green, the DSL domain in yellow,
and the C2 domain in blue. The Ca2+ ions bound in EGF11, EGF12, and EGF13
are shown as red spheres.
(Bottom) The model is rotated by 180 about the x axis.onto Notch EGF11-13 in the structure of the complex solved by
Luca et al. (2015) (Figure 5). This shows a potential interaction
between Notch EGF10 and the EGF1 domain of Dll-4. Although
there are some steric clashes between the two domains, these
could be alleviated by small reorientation of the two domains.
It is interesting to note that the putative interface includes resi-
dues that are not conserved between Dll and Jagged ligands,
suggesting that this additional site could contribute to differ-
ences in binding.
Comparative Binding of EGF9-13, EGF10-13, and
EGF11-13 to Dll-4 and J1
The influence of the rigid interface between EGF10 and EGF11
on the binding to Dll-4 was probed using an established flow
cytometry assay (Figure 6A) (Cordle et al., 2008b; Taylor et al.,
2014). Addition of EGF10 to EGF11-13 was found to decrease
binding to cells expressing full-length human Dll-4. Addition
of EGF9, which has been shown in this study to have a flexible
linkage to EGF10, had no further inhibitory effect on binding of
EGF11-13 to Dll-4. These data suggest that the N-terminal
flanking domain EGF10 modulates the binding of EGF11-13 to
Dll-4 but that EGF9 does not. These experiments were repeated
with Jagged1-expressing cells (Figure 6B). In contrast to Dll-4,
the addition of EGF10 to EGF11-13 did not decrease the bind-
ing, indicating that the modulatory effect of EGF10 is specific
to Dll-4.DISCUSSION
This study has examined the effect of non-Ca2+-binding EGF do-
mains on the shape of the EGF4-13 region of Notch. Themajority
of EGF domains in this region bind Ca2+, which confers the
expected rigidity to the domain interface formed between the
cbEGF domain and the preceding N-terminal EGF domain.
Various solution NMR and X-ray structures have confirmed pre-
viously that high-affinity Ca2+ binding to the C-terminal EGF
domain of a pair is predictive for a rod-like organization for
tandem cbEGF domains and EGF-cbEGF pairs (Cordle et al.,
2008a; Downing et al., 1996; Hambleton et al., 2004; Smallridge
et al., 2003) and for heterologous cbEGF domain pairs (Jensen
et al., 2005). In these structures, Ca2+ affinity is enhanced and
a rigid structure is stabilized via interaction with a packing aro-
matic residue located between the fifth and sixth cysteine in
the preceding domain (Figure S1).
The Kd values for Ca
2+ binding to Notch EGF domains,
measured by chromophoric chelation or by NMR spectroscopy,
indicate moderate- to high-affinity sites (1–200 mM, I = 0.15,
pH 7.5), which would be expected to be saturated under the
physiological conditions of the extracellular milieu and insensi-
tive to changes in Ca2+ flux at the cell membrane. However,
the two non-Ca2+-binding EGF domains (EGF6 and EGF10)
confer very different properties to the region. Both crystallog-
raphy and NMR analysis demonstrate that the EGF5-6 interface
is bent and rigid, introducing a tilt angle of 70–90, while the
EGF9-10 interface is flexible. Thus, unlike the cbEGF domain,
the non-Ca2+-binding EGF, when in a C-terminal position, can
confer very different properties to a domain interface, which
are not obviously predictable from sequence.
Utilizing the new structural information from this study,
together with published data for the EGF11-13 ligand-binding re-
gion (Cordle et al., 2008a), it is possible to construct a newmodel
of the EGF4-13 region. The presence of a flexible linker between
EGF9-10 separates the region into two rigid halves; EGF4-9,
containing the bent interface between EGF5-6, and a near-linear
section comprising EGF10-13 (Figure 4). It is interesting to note
that two residues, A420 and N421, in Notch1, which we showed
were present in a highly flexible loop between the first and sec-
ond cysteine of Notch EGF11, are observed to pack against two
residues R191 and F195 in the DSL domain that are highly
conserved across the two Notch ligand families and are pro-
posed by Luca et al. (2015) ‘‘to be a conserved focal point for
ligand binding.’’
The rigid interface formed between EGF10-11 provides new
information with which to model the receptor-ligand complex.
Superposition of the EGF10-13 region on the structure of the
Notch/Dll-4 complex shows that, instead of facing away from
the ligand, EGF10 is in close proximity, suggesting a possible
contact site between Notch EGF10 and Dll-4 EGF1 (Figure 5).
Previous studies have observed that EGF1 and 2 enhance bind-
ing of the J1 N terminus, comprising the C2 and DSL domains, to
Notch. This could be an indirect effect of EGF1 on DSL structural
integrity and/or additional specific contacts made between
ligand and receptor at the EGF1/EGF10 interface (Shimizu
et al., 1999).
The five-residue flexible linker between EGF9 and 10 is likely
to preclude folding back (via a U-shaped structure at EGF9-10)Structure 24, 555–566, April 5, 2016 ª2016 The Authors 561
Figure 6. Interaction of EGF11-13, EGF10-13, and EGF9-13 Constructs of Human Notch1 with DLL-4 and J1
(A and B) Biotinylated hNotch1 EGF11-13 and (left) EGF10-13 or (right) EGF9-13 were bound to avidin-coated fluorescent beads and incubatedwith B16F10 cells
expressing mDLL-4 (A) or mJ1 (B). The shift to the right away from the control protein (solid gray) shows binding of the EGF11-13 construct (black line) to mDLL-4
and mJ1. A reduction in binding, indicated by the black arrow, is seen for the EGF10-13 and EGF9-13 constructs (red line) to Dll-4 while no significant change is
seen with mJ1.of the EGF4-9 region such that it would impede the core recog-
nition region of EGF11-12 by direct interactions. Instead, the
near-linear section of EGF6-9, upstream of the flexible linkage
at EGF9-10, suggests that Notch may align with ligand along
its longitudinal axis, and overall a number of weak interactions
along the length of the molecule may contribute to the overall
binding affinity of receptor to ligand (Figure 7A). EGF8 of Notch,
for example, could come into close proximity with EGF3 of
the ligand. This could explain the influence of mutation of a
conserved residue in EGF8 (V361M), which selectively affects
Drosophila Serrate binding (Yamamoto et al., 2012). Further-
more, post-translational O-glycosylation modifications could
further stabilize this interface. Because of the flexible linker be-
tween EGF9 and EGF10, it is not possible to identify specific
interaction faces from our model.
Luca et al. (2015) have postulated that, as a consequence
of the antiparallel orientation of the Notch/Dll-4 complex, there
may be a single Notch/ligand complex that forms at the cell sur-562 Structure 24, 555–566, April 5, 2016 ª2016 The Authorsface in cis and in trans. This would necessitate a rotation, C-ter-
minal of the core recognition region within each protein to main-
tain the binding interface. The identification of a flexible cbEGF/
EGF linker in this study suggests that a homologous domain pair
within each molecule could facilitate the necessary rotation.
Since we postulated that EGF10 was likely to make contacts
with EGF1 of Dll-4 ligand, we compared the ligand binding of
two fragments, EGF10-13 and EGF9-13, with that of the core
recognition fragment EGF11-13. Utilizing a well-established
flow cytometry assay, we demonstrated that the presence of
EGF10 substantially reduced binding to Dll-4 (compared with
that observed with EGF11-13). The addition of EGF9 did not
further reduce binding. These data can be explained if addition
of EGF10, which may have a steric clash with EGF1 of Dll-4,
requires the readjustment of the positions of EGF10 and
EGF1, which in turn affects the EGF11-DSL interaction site.
It is notable that in the structure of the Notch/Dll-4 com-
plex, where EGF11 is in a non-native context (not bound to
AB C
Figure 7. Cartoon Representation of Possible Notch/Ligand Interac-
tions and the Effect of Addition of EGF10 on the Interaction of
EGF11-13 with Ligand
(A) Notch EGF11/EGF12 and Dll-4 DSL/C2 domains have been shown to
interact at two sites (Luca et al., 2015). Our near-linear orientation for hN1
EGF6-9, upstream of the flexible linkage at EGF9-10 (indicated by the blue
arrow above the linker), suggests that Notch may align with ligand along its
longitudinal axis. The Ca2+-binding EGF domains are shown in green, other
EGF domains in wheat, the DSL domain in yellow, and the C2 domain in blue.
The Dll-1, Dll-4, J1, and J2 ligands all share the C2-DSL-EGF1-3 architecture.
Dll-1 and Dll-4 have a further five EGFs while J1 and J2 have a further 13 EGFs.
(B) In the X-ray structure of the Notch/Dll-4 complex, where EGF11 is in a non-
native context (not bound to EGF10), EGF11 makes many more stabilizing
contacts with DSL than EGF12 does with the C2 domain. The vertical lines in
gray indicate stabilizing interactions between pairs of domains.
(C) It is plausible that covalent linkage of EGF10 to EGF11-13 results in a steric
clash between EGF10 and EGF1, and that small rearrangements that occur
upon interaction with Dll-4 could disrupt some EGF11-mediated contacts
within the N-terminal region of this domain. New contacts made between
EGF10 and EGF1 are not sufficient to overcome the loss of EGF11-mediated
contacts, since Notch EGF10-13 binds less well to Dll-4 than EGF11-13. The
dashed gray line and the ? are used to indicate a possible interaction.EGF10), EGF11 makes many more protein:protein contacts
with DSL than EGF12 does with the C2 domain. It is therefore
plausible that covalent linkage of EGF10 and small rearrange-
ments that occur on interaction with Dll-4 could disrupt some
EGF11-mediated contacts within the N-terminal region of this
domain (Figures 7B and 7C). If that is the case, then new con-
tacts made between EGF10 and EGF1 are not sufficient to
overcome the loss of EGF11-mediated contacts, since Notch
EGF10-13 binds less well to Dll-4 than EGF11-13. The lack of
any further effect of EGF9 is consistent with the flexible nature
of the EGF9-10 linker.
We previously observed a similar reduction in binding to Dll-1
when comparing the binding of EGF10-14 with that of EGF11-14
and postulated a steric effect in the absence of structural data,
which our current model confirms (Cordle et al., 2008b). Quanti-
tative measurements by surface plasmon resonance showed a
decreased affinity (Kd increases from 130 mM to 200 mM), indi-
cating that not all contacts between DSL of Dll-1 and EGF11
are lost as a consequence of EGF10 addition. The importance
of the EGF10-11 interface in modulating ligand binding wasfurther shown by the introduction of a Ca2+-binding-site NG
substitution in EGF11. This decouples the rigid interface be-
tween EGF10-11, which causes the steric clash with ligand,
and restores binding. It is notable that the effect of EGF10
is ligand specific and observed only with the Delta family of li-
gands. This can be reconciled by the ligand-specific differences
in amino acid sequences within the DSL domain, which are
reflected in the substantially weaker binding of unmodified
EGF11-13 to J1 compared with Dll-4 (Taylor et al., 2014), and
at the proposed interface involving EGF1.
Our model for the EGF4-13 region identifies the architecture of
Notch in the absence of any post-translational modification such
as O-glycosylation and gives new insight into the organization of
Notch/ligand complexes. Previous publications of Taylor et al.
(2014) and Luca et al. (2015) have demonstrated that O-glycosyl-
ation of residues within the ligand-binding region in EGF11 and
EGF12 can contribute directly to the binding interface be-
tween ligand and receptor, and many studies have indicated
that O-glycosylation at other sites along Notch can influence
signaling activity. Our unmodified EGF domain studies demon-
strate that, in the absence of O-glycans in EGF11 and EGF12,
we observe an inhibitory effect of EGF10 on Dll-4 and Dll-1 bind-
ing, but not on J1. It is therefore interesting to postulate that
O-glycosyltransferase-mediated addition of O-glycans within
EGF11, in addition to Fringe-mediated additions to EGF12, could
be an additional mode of regulation used to modulate Notch
signaling, particularly by the Delta family of ligands.
In summary, our unmodified EGF domain studies have pro-
vided new information about the shape of the Notch extracellular
domain and the importance of determining the individual proper-
ties of common domain interfaces. They provide a platform to
understand the basal architecture of the extracellular region of
Notch, which may be further modified by O-glycosylation to
fine-tune interactions with a repertoire of ligands.EXPERIMENTAL PROCEDURES
Protein Expression, Purification, Refolding, and Characterization
Protein expression, isotopic labeling, refolding, and purification protocols have
been described previously (Muranyi et al., 2004; Weisshuhn et al., 2015a,
2015b; Whiteman et al., 2014). Protein fragments were expressed in Escheri-
chia coli BL21 cells transformed with a pQE30 (Qiagen)-based protein expres-
sion construct and a pREP4 plasmid for control of expression via the Lac
Repressor. All expression vectors contained an N-terminal His6 tag for purifi-
cation and either a factor Xa (EGF4-7, EGF5-7, EGF10-13, EGF11-13) or an
enterokinase (EGF8-11) recognition site for later removal of the His6 tag. The
tag was not cleaved for EGF7-9 and EGF9-11; the His6 tag shows no evidence
of Ca2+ binding. The final protein products were analyzed by SDS-PAGE
(Figure S4).
NMR Spectroscopy
All NMRexperimentswere carried out using spectrometers operating at 1H fre-
quencies ranging from 500 to 950 MHz. The spectrometers are equipped with
Oxford Instruments magnets and home-built triple-resonance pulsed-field
gradient probes. Data were processed using NMRPipe (Delaglio et al., 1995)
and spectra were analyzed using the CCPN software (Vranken et al., 2005).
Resonance assignments for EGF4-7, EGF8-11, and EGF11-13 have been
described previously (Muranyi et al., 2004; Weisshuhn et al., 2015a, 2015b)
(Biological Magnetic Resonance Bank accession numbers 25172, 25533,
6031). 3D 15N-edited total correlation spectroscopy-heteronuclear single
quantum coherence (HSQC) and NOE spectroscopy (NOESY)-HSQC spectra
were collected to assign the 1H-15N HSQC spectrum of EGF7-9.Structure 24, 555–566, April 5, 2016 ª2016 The Authors 563
Unless otherwise stated, all NMR experiments were carried out at 25C in
5 mM Tris-HCl at pH 7.5 in 95% H2O/5% D2O. Protein samples for measure-
ment of the {1H} -15N heteronuclear NOE or 1H-15N RDCs contained at least
25 mMCaCl2 to ensure all Ca
2+-binding sites were saturated. Further informa-
tion about the NOE experiments and the collection and analysis of RDC data
can be found in Supplemental Experimental Procedures.
Measurement of Ca2+ Dissociation Constants
For Ca2+ titrations monitored by NMR, protein samples were prepared in 5mM
Tris-HCl buffer (pH 7.5) made with 99.9% D2O containing 150 mM NaCl (to
maintain approximate physiological ionic strength I = 0.15); samples were
initially Ca2+ free and the Ca2+ concentration was increased by addition of
CaCl2 aliquots up to saturating concentrations (usually >25 mM). Ca
2+ binding
was monitored using 2D 1H-1H NOESY spectra collected with a mixing time of
150 ms (Jensen et al., 2005; Smallridge et al., 1999; Suk et al., 2004).
Ca2+ dissociation constants for high-affinity sites were determined by
competition with the chromophoric chelator 5,50-Br2BAPTA (Jensen et al.,
2005; Linse et al., 1991; Suk et al., 2004). Solutions of proteins in Ca2+-free
buffer (5 mM Tris [pH 7.5], 150 mM NaCl) were titrated with Ca2+-stock buffer
(5 mM Tris [pH 7.5], 1 mM CaCl2, 150 mM NaCl) in the presence of 5,5
0-
Br2BAPTA (Kd of 1.6 mM under these conditions). All titrations were performed
with 20–30 mM chelator and 20–30 mM protein at room temperature (approx.
23C) using a Shimadzu UV mini 1240 spectrophotometer. Dissociation con-
stants were calculated by least-squares fitting to the data using in-house soft-
ware (Linse et al., 1991; Stenberg et al., 1997). Each titration was repeated
at least three times. Experimental data were fitted to models with one or
two high-affinity Ca2+ binding sites, and the most suitable model was chosen
using an F test. This method is suitable for defining Ca2+ Kd values in the range
of 1–20 mM.
X-Ray Crystallography
Human Notch1 EGF4-7 was crystallized by vapor diffusion from sitting drops
with 25% mother liquor and protein at 14 mg/ml in 50 mM Tris (pH 7.4), 1 mM
CaCl2. Commercially available mother liquor from Molecular Dimensions was
used. The P21 form crystallized in 0.1 M sodium cacodylate (pH 6.5) with 18%
w/v PEG 2000 MME. The C2 form crystallized in 0.2 M imidazole malate
(pH 8.5) with 7.5% w/v PEG 10,000. The Diamond facility was used for data
collection (beamline I03). Both datasets were indexed and scaled using Xia2
(Winter, 2010). The structure was phased using molecular replacement of ca-
nonical EGF domains in Phaser (Mccoy et al., 2007). Structures were refined
using the program Autobuster with the graphics program COOT used for
manual rebuilding and inspection (Bricogne et al. 2011; Emsley and Cowtan,
2004). MolProbity was used to determine structural quality (Chen et al., 2010).
Flow Cytometry Binding Assay
Flow cytometry was carried out as described previously (Whiteman et al.,
2013). Briefly, biotinylated human Notch1 EGF11-13, EGF10-13, and EGF9-
13 were coupled to avidin-coated purple fluorescent beads (Spherotech)
and added to B16F10 cells expressingmDll-4 or mJagged1. Following incuba-
tion, samples were analyzed directly by flow cytometry without removal of
unbound beads.
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